| - Industry | - Sector | - CEO | XNSE Exchange | - ISIN |
| India Country | 399 Employees | - Last Dividend | 26 Mar 2025 Last Split | - IPO Date |
Beta Drugs Limited is a prominent Indian company founded in 1985, located in Panchkula, India. The organization specializes in the development, manufacturing, and selling of anti-cancer bulk drugs and finished dosages. With a commitment to healthcare advancements, Beta Drugs Limited not only focuses on oncology but also delves into cosmeceutical products. The company is equipped to manufacture active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI), catering to both domestic and international markets through its export services.
Beta Drugs Limited develops a range of bulk drugs specifically designed for cancer treatment, ensuring high-quality solutions in the fight against various types of cancer. These products are essential for formulating effective treatment regimens and are crafted using advanced techniques.
The company produces finished dosage forms that make it easier for patients to receive necessary treatments. These products encompass a range of formulations tailored to enhance therapeutic efficacy and improve patient compliance.
In addition to oncology, Beta Drugs Limited offers a line of cosmeceuticals, which are cosmetic products with therapeutic benefits. This segment is dedicated to skin health, providing formulations that promote skin repair and rejuvenation.
The manufacturing of APIs is a core competency of Beta Drugs Limited, producing high-purity ingredients that serve as the foundational components in various pharmaceutical formulations. These APIs are crucial for the development of effective medications.
Beta Drugs Limited also focuses on the production of pharmaceutical formulation intermediates, which play a vital role in the drug manufacturing process, helping to streamline and enhance the formulation of end products.
The company exports its pharmaceutical products, expanding its reach to global markets and contributing to international healthcare solutions. This enables Beta Drugs Limited to offer its expertise beyond India, fostering improved health outcomes worldwide.